↓ Skip to main content

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer

Overview of attention for article published in Frontiers in oncology, January 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
9 X users
facebook
1 Facebook page

Readers on

mendeley
143 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
Published in
Frontiers in oncology, January 2018
DOI 10.3389/fonc.2018.00003
Pubmed ID
Authors

Taku Fujimura, Yumi Kambayashi, Yasuhiro Fujisawa, Takanori Hidaka, Setsuya Aiba

Abstract

Tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) are significant components of the microenvironment of solid tumors in the majority of cancers. TAMs sequentially develop from monocytes into functional macrophages. In each differentiation stage, TAMs obtain various immunosuppressive functions to maintain the tumor microenvironment (e.g., expression of immune checkpoint molecules, production of Treg-related chemokines and cytokines, production of arginase I). Although the main population of TAMs is immunosuppressive M2 macrophages, TAMs can be modulated into M1-type macrophages in each differential stage, leading to the suppression of tumor growth. Because the administration of certain drugs or stromal factors can stimulate TAMs to produce specific chemokines, leading to the recruitment of various tumor-infiltrating lymphocytes, TAMs can serve as targets for cancer immunotherapy. In this review, we discuss the differentiation, activation, and immunosuppressive function of TAMs, as well as their benefits in cancer immunotherapy.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 143 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 25 17%
Student > Bachelor 20 14%
Student > Master 12 8%
Researcher 10 7%
Student > Doctoral Student 8 6%
Other 19 13%
Unknown 49 34%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 26 18%
Agricultural and Biological Sciences 15 10%
Immunology and Microbiology 13 9%
Medicine and Dentistry 13 9%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Other 15 10%
Unknown 54 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2018.
All research outputs
#7,050,597
of 25,382,440 outputs
Outputs from Frontiers in oncology
#2,370
of 22,428 outputs
Outputs of similar age
#133,422
of 450,227 outputs
Outputs of similar age from Frontiers in oncology
#20
of 82 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 22,428 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,227 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.